GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,565 Cr | ₹1,398 Cr | ₹729 Cr | ₹582 Cr | ₹513 Cr |
What is the latest Total Current Liabilities ratio of GLAND PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,565 Cr |
| Mar2024 | ₹1,398 Cr |
| Mar2023 | ₹729 Cr |
| Mar2022 | ₹582 Cr |
| Mar2021 | ₹513 Cr |
How is Total Current Liabilities of GLAND PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,565 Cr | 11.91 | |
| Mar2024 | ₹1,398 Cr | 91.78 | |
| Mar2023 | ₹729 Cr | 25.28 | |
| Mar2022 | ₹582 Cr | 13.56 | |
| Mar2021 | ₹513 Cr | - | |
Compare Total Current Liabilities of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹39,229.6 Cr | -3% | 3.4% | 23.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -3% |
3.4% |
23.8% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses